Skip to main content
Journal cover image

Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.

Publication ,  Journal Article
Abern, MR; Tsivian, M; Polascik, TJ
Published in: Curr Urol Rep
April 2012

Focal therapy for prostate cancer has been increasingly utilized with the goal of effective disease control while maximizing patient functional outcomes. The optimal patient selection criteria are not known and therefore are not standardized. This review compares the available expert panel consensus guidelines with the selection criteria utilized in recently published focal therapy trials. Because the data from focal trials are still maturing, the currently enrolling clinical trials are reviewed as well. In addition, the recent literature regarding technological advances in prostate biopsy and imaging strategies are added to the current guidelines to recommend a rationale for patient selection.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Curr Urol Rep

DOI

EISSN

1534-6285

Publication Date

April 2012

Volume

13

Issue

2

Start / End Page

160 / 169

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Ultrasound, High-Intensity Focused, Transrectal
  • Treatment Outcome
  • Survival Analysis
  • Risk Assessment
  • Randomized Controlled Trials as Topic
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Prognosis
  • Practice Guidelines as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Abern, M. R., Tsivian, M., & Polascik, T. J. (2012). Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria. Curr Urol Rep, 13(2), 160–169. https://doi.org/10.1007/s11934-012-0241-5
Abern, Michael R., Matvey Tsivian, and Thomas J. Polascik. “Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.Curr Urol Rep 13, no. 2 (April 2012): 160–69. https://doi.org/10.1007/s11934-012-0241-5.
Abern MR, Tsivian M, Polascik TJ. Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria. Curr Urol Rep. 2012 Apr;13(2):160–9.
Abern, Michael R., et al. “Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.Curr Urol Rep, vol. 13, no. 2, Apr. 2012, pp. 160–69. Pubmed, doi:10.1007/s11934-012-0241-5.
Abern MR, Tsivian M, Polascik TJ. Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria. Curr Urol Rep. 2012 Apr;13(2):160–169.
Journal cover image

Published In

Curr Urol Rep

DOI

EISSN

1534-6285

Publication Date

April 2012

Volume

13

Issue

2

Start / End Page

160 / 169

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Ultrasound, High-Intensity Focused, Transrectal
  • Treatment Outcome
  • Survival Analysis
  • Risk Assessment
  • Randomized Controlled Trials as Topic
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Prognosis
  • Practice Guidelines as Topic